Embolism News and Research

RSS

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Researchers determined whether the incidence of new diabetes mellitus (DM) and cardiovascular diseases (CVDs) increases in a year among those recovering from COVID-19.

21 Jul 2022

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes, particularly in the three months following infection, according to a new study by Emma Rezel-Potts, Martin Gulliford, and colleagues of King's College London, United Kingdom, publishing July 19th in the open access journal PLOS Medicine.

20 Jul 2022

AI vs. clinical reports for the detection of incidental pulmonary embolus on chest CT

According to ARRS' American Journal of Roentgenology (AJR), an AI tool for detection of incidental pulmonary embolus (iPE) on conventional contrast-enhanced chest CT examinations had high NPV and moderate PPV for detection, even finding some iPEs missed by radiologists.

13 Jul 2022

Increased risk of maternal morbidity is associated with maternal age, obesity, and previous C-section

New research from Scotland published in Anaesthesia (a journal of the Association of Anaesthetists) shows the increased risk of severe maternal sickness/complications (morbidity) is associated with a range of risk factors including increasing maternal age and levels of obesity, and also previous Cesarean section.

13 Jul 2022

Risk factors associated with shoulder surgery are low, but some need further surgery within a year

Rates of serious complications associated with shoulder surgery are low, but one in 26 patients need further surgery within a year, finds a study in The BMJ today.

7 Jul 2022

SARS-CoV-2 infection of lung endothelial cells and pulmonary capillary microthrombosis

Researchers evaluated the presence of RNA of SARS-CoV-2 in lung tissue of deceased patients.

4 Jul 2022

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

A new study examined electronic health records for approximately half the population of Denmark, looking for people with a diagnosis of COVID-19 or hospitalized with community-acquired pneumonia.

30 Jun 2022

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Scientists have provided a detailed overview on the long-term symptoms experienced by COVID-19 patients after initial primary infection with SARS-CoV-2.

30 Jun 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

One in 500 men may carry an extra X or Y chromosome which could increase risk of several diseases

Around one in 500 men could be carrying an extra X or Y chromosome – most of them unaware – putting them at increased risk of diseases such as type 2 diabetes, atherosclerosis and thrombosis, say researchers at the universities of Cambridge and Exeter.

10 Jun 2022

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

Researchers evaluated the incidence of post-COVID-19 conditions among adults in the United States.

26 May 2022

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated negative D-dimer tests, instead of continuing with low-dose anticoagulant (apixaban).

20 May 2022

Embolism News and Research

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

UK study finds an increase in cardiovascular diseases and diabetes up to 12 months after COVID-19

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes

AI vs. clinical reports for the detection of incidental pulmonary embolus on chest CT

Increased risk of maternal morbidity is associated with maternal age, obesity, and previous C-section

Risk factors associated with shoulder surgery are low, but some need further surgery within a year

SARS-CoV-2 infection of lung endothelial cells and pulmonary capillary microthrombosis

Ischemic stroke risk may be higher after COVID-19 compared to flu or bacterial pneumonia

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

One in 500 men may carry an extra X or Y chromosome which could increase risk of several diseases

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

Study investigates COVID-19 vaccination in pregnancy

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

Incidence of venous thromboembolism following COVID-19 vaccination

Cancer patients with non-O blood types face higher risk of developing blood clots

COVID-19 increases risk of bleeding, DVT, and pulmonary embolism

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News